Carboplatin: Platinum-Based DNA Synthesis Inhibitor for C...

2026-01-20

Carboplatin is a rigorously validated platinum-based DNA synthesis inhibitor for cancer research. It demonstrates robust, quantifiable antiproliferative effects in ovarian and lung carcinoma models and is widely used for benchmarking DNA damage response and repair inhibition. This article details its mechanism, experimental benchmarks, and integration parameters for preclinical oncology workflows.